Phase II trial of sapacitabine for solid tumours.
Latest Information Update: 31 Dec 2012
At a glance
- Drugs Sapacitabine (Primary)
- Indications Breast cancer; Lung cancer; Ovarian cancer; Pancreatic cancer; Solid tumours
- Focus Therapeutic Use
- Sponsors Cyclacel Pharmaceuticals
- 31 Dec 2012 New trial record